LA PHARMACIE DU PARC
ActiveLA PHARMACIE DU PARC has been active since 1952 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €92k and a net result of €21k. Equity is growing by ~55.5% per year across the filed fiscal years. Its solvency ranks better than 59% of 4137 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▼-9
Solvency69▲+14
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 1.79 against 1.41 in 2024; short-term debt: 54.2% and cash: 28% of total assets), but 56.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
43.9%
Return on assets
9.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-04-2026, 98 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
98 d early
2024
38 d early
2023
49 d early
2022
29 d late
2021
29 d late
2020
17 d late
2019
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€21k▼ 47.2%
2024 · €39k
2018: €-10k
2019: €-4k
2020: €45k
2021: €48k
2022: €28k
2023: €-17k
2024: €39k
2018 → 2025
Working capital
€91k▲ 36.6%
2024 · €66k
2018: €-45k
2019: €-24k
2020: €21k
2021: €21k
2022: €48k
2023: €25k
2024: €66k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€21k-€49k▲ 134%€32k▼ 34.4%€72k▲ 122%€92k▲ 29.1%
Operating result€67k-€37k▼ 45.0%€-20k€51k€29k▼ 42.9%
Net result€48k-€28k▼ 41.4%€-17k€39k€21k▼ 47.2%
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 43% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €211k
Fixed assets
€6k▼ 20.7%
Current assets
€205k▼ 10.8%
Equity and liabilities €211k
Equity
€92k▲ 29.1%
Debt
€118k▼ 28.5%
The debt ratio falls from 69.7% to 56.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€30k▼
2024 · €52k
Cash flow
€22k▼
2024 · €41k
Solvency
43.9%▲
2024 · 30.3%
Current ratio
1.79▲
2024 · 1.41
Quick ratio
1.09▲
2024 · 0.77
Debt / equity
1.28▼
2024 · 2.30
ROE
22.5%▼
2024 · 55.0%
ROA
9.9%▼
2024 · 16.6%
Interest coverage
26.75▼
2024 · 47.90
Debt
€118k▼
2024 · €165k
Debt ≤ 1 year
€114k▼
2024 · €163k
Income taxes
€8k▼
2024 · €11k
Staff costs
€209k▲
2024 · €204k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€237k€211k▼
Fixed assets21/28€7k€6k▼
Tangible fixed assets22/27€7k€6k▼
Plant, machinery and equipment23€5k€5k▼
Furniture and vehicles24€744-
Other tangible fixed assets26€1k€1k▼
Financial fixed assets28€50€50=
Current assets29/58€230k€205k▼
Stocks and contracts in progress3€104k€80k▼
Stocks30/36€104k€80k▼
Amounts receivable within one year40/41€83k€66k▼
Trade receivables40€78k€57k▼
Other amounts receivable41€6k€9k▲
Cash at bank and in hand54/58€41k€59k▲
Deferred charges and accrued income490/1€1k€36▼
Equity and liabilities
Total equity and liabilities10/49€237k€211k▼
Equity10/15€72k€92k▲
Contributions10/11€20k€20k=
Profit (loss) carried forward14€51k€72k▲
Amounts payable17/49€165k€118k▼
Amounts payable within one year42/48€163k€114k▼
Trade debts44€89k€86k▼
Suppliers440/4€89k€86k▼
Taxes, remuneration and social security45€31k€26k▼
Taxes450/3€3k€82▼
Remuneration and social security454/9€28k€26k▼
Other amounts payable47/48€43k€2k▼
Accrued charges and deferred income492/3€2k€4k▲
Income statement
Code20242025
Remuneration, social security and pensions62€204k€209k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€1k▼
Other operating charges640/8€3k€2k▼
Gross operating margin9900€260k€241k▼
Operating profit (loss)9901€51k€29k▼
Financial income75/76B€811€937▲
Recurring financial income75€811€937▲
Financial charges65/66B€1k€1k▲
Recurring financial charges65€1k€1k▲
Profit (loss) for the period before taxes9903€50k€29k▼
Income taxes67/77€11k€8k▼
Profit (loss) for the period9904€39k€21k▼
Profit (loss) for the period to be appropriated9905€39k€21k▼
Appropriation of the result
Profit (loss) to be appropriated9906€51k€72k▲
Profit (loss) brought forward from the previous period14P€12k€51k▲
Social balance
Average headcount (FTE)90873.32.5▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-04
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
30-03
State Gazette act
Resignations & appointmentsDirector resignation · Director discharge8 facts ▸
State Gazette act
Resignations & appointments
Director resignation · Director discharge8 facts ▸
- Director resignation, Alain CLABOTS (administrateur)
- Director resignation, Benoît CLABOTS (administrateur)
- Director resignation, Vincent CLABOTS (administrateur)
- Director resignation, Agnès PEETERS (administrateur)
- Director discharge, Alain CLABOTS
- Director discharge, Benoît CLABOTS
- Director discharge, Vincent CLABOTS
- Director discharge, Agnès PEETERS
2025
23-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Back to profitnet €39k
Net result €39k after one loss-making year.
12-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial
Weakest financial yearnet €-17k ▼160%
Net result drops to €-17k, the lowest in the series; recovery starts the following year.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 29 days late
2021
31-12
Financial
Highest result since 2018net €48k ▲7.2%
Operating result €67k, net result €48k, both a record.
17-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 17 days late
2020
31-12
Financial
Back to profitnet €45k
Net result €45k after 2 loss-making years.
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 31 days late
2019
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
16-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
08-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 8 days late
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
28-02-2026
Alain CLABOTS: Resigned as Director
28-02-2026
Benoît CLABOTS: Resigned as Director
28-02-2026
Peeters Agnès: Resigned as Director
28-02-2026
Vincent CLABOTS: Resigned as Director
08-03-2022
Alain CLABOTS: Resigned as Manager
20-12-2017
Peeters Agnès: Resigned as Managing director
Location & real-estate footprint
Registered office, Grez-Doiceau · 1 establishment unit since 2026
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chaussée de Wavre 4081390 Grez-DoiceauGround area
688 m²
Building footprint
76 m²
Volume, LiDAR
520 m³
Parcel 25001C0040/00T000, Wallonia · tallest building 8.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Pharmacie du Parc
since 20262.388.303.118
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25001C0040/00T000 | Wallonia | 688 m² | 1 · 75 m² | 8.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
APOTHEEK LAURYSSEN
BE 0459.848.492
Antwerpen · Eq €92k
PHARMACIE DELEUSE - DARCIS
BE 0473.628.630
Bassenge · Eq €93k
APO CASDAN
BE 0847.478.904
Schoten · Eq €92k
Apotheek Zwaneven
BE 0820.789.551
Oud-Turnhout · Eq €93k
Apotheek Donk
BE 0674.543.542
Herk-de-Stad · Eq €92k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,374 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded07-03-1952
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 48 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.